Authors:
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX
Philip S. Brachman, MD – Atlanta Infectious Disease Group, Atlanta, GA
Fernando S. Alvarado, MD – Infectious Disease Consultants, Altamonte Springs, FL
Jennifer L. Christensen – Healix Infusion Therapy, Inc., Sugar Land, TX
